Overview

A Study to Evaluate the Analgesic Efficacy and Safety of V120083 in Subjects With Osteoarthritis (OA) of the Knee

Status:
Completed
Trial end date:
2017-11-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the analgesic efficacy of V120083 twice daily compared to placebo in subjects with moderate to severe chronic pain due to OA of the knee.
Phase:
Phase 2
Details
Lead Sponsor:
Purdue Pharma LP
Collaborator:
Shionogi
Treatments:
Analgesics
Naproxen